Reaction

Tonsil Cancer reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 801 reports · 5 co-occurring drugs

As of the last recalculation, Tonsil Cancer appears in 801 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 33.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ciclesonide	17	33.1	33.2
Febuxostat	16	25.3	25.3
Ranitidine Hydrochloride	31	15.4	15.4
Ranitidine	65	9.2	9.2
Ixekizumab	9	6.4	6.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.